Olivier Brandicourt Bei Gene, Ltd. (BGNE) insider trading activity

Olivier Brandicourt is Director of BeiGene, Ltd.. Currently has a direct ownership of 16,341 shares of BGNE, which is worth approximately $3.24 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 16,341 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.3K

0% 3M change

n/a 12M change

Total Value Held $3.24 Million

OLIVIER BRANDICOURT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 05 2024	BUY Grant, award, or other acquisition	-	16,341 Added 50.0%	16,341 Ordinary Shares

Also insider at

ALNY

ALNYLAM PHARMACEUTICALS, INC. Healthcare

Director